跳至主要内容
临床试验/NCT05009407
NCT05009407已完成不适用

CD160 Ans Corneal Graft: Expression in Corneal Vessels

CHU de Reims1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2021年4月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
CHU de Reims
入组人数
43
试验地点
1
主要终点
Micro-vascular densities

研究概览

简要总结

Despite improvements in corneal transplantation, anti-angiogenic and anti-lymphangiogenic factors remain to be be identified. CD160 is an anti-angiogenic target: its expression seems to be restricted to some immune cells and to activated endothelial cells. We hypothesized that CD160 is expressed in blood and lymphatic human corneal neovessels and is involved in corneal graft rejection pathogenesis

详细描述

After informed consent, patients enrolled for corneal graft surgery at the Robert Debré University Hospital, Reims, France, will be included.

Routine general and eye examination including cornea photographs will be performed.

During surgery, a quarter of patients' cornea and of donors' corneoscleral rim will be spared for immunohistochemistry analyzes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-year-old or more patients
  • enrolled for penetrating keratoplasty or deep anterior lamellar keratoplasty surgeries at the Robert Debré University Hospital, Reims, France
  • considered able to give an informed written consent

排除标准

  • 未提供

研究组 & 干预措施

HOSTS

patients ongoing corneal transplantation procedure which a full-thickness cornea from the host is replaced by a graft from a donor

干预措施: Immunohistochemistry and clinical analyses on patients and corneas (Biological)

DONORS

grafts from donors that would be analyzed

干预措施: Immunohistochemistry and clinical analyses on patients and corneas (Biological)

结局指标

主要结局

Micro-vascular densities

时间窗: 1 year

neovascularization scores quantification of blood (anti-ERG+/anti-D2-40-) and lymphatic (anti-ERG+/anti-D2-40+) vascular structures ; Percentages of those vascular structures marked with anti-CD160

次要结局

  • Percentages of those vascular structures marked with anti-CD160 and/or CD105 and/or aSMA(1 year)
  • Evaluation of clinical blood vascular densities on photographs with help of ImageJ software(1 year)

研究者

发起方
CHU de Reims
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验